Park Ha Biological Technology (BYAH) Invested Capital (2024 - 2026)

Park Ha Biological Technology (BYAH) has reported Invested Capital for 3 consecutive years, with -$3.5 million the latest figure, recorded in Q2 2026.

• Quarterly Invested Capital changed N/A year-over-year to -$3.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$5.2 million (changed N/A YoY) and the FY2025 annual result came in at -$3.2 million, down 317.98% from the prior year.
• Invested Capital fell to -$3.5 million in Q2 2026 per BYAH's latest filing, from -$3.2 million in the prior quarter.
• Over the last five years, Invested Capital for BYAH reached as high as $1.5 million in Q4 2024 and fell as low as -$3.5 million in Q2 2026.
• A 3-year average of -$1.7 million and a median of -$3.2 million in 2025 frame the typical range for Invested Capital.
• The largest YoY upside for Invested Capital was 317.98% in 2025 against a maximum downside of 317.98% in 2025.
• Year by year, Invested Capital stood at $1.5 million in 2024, then tumbled by 317.98% to -$3.2 million in 2025, then declined by 9.23% to -$3.5 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered -$3.5 million, -$3.2 million, and $1.5 million for Q2 2026, Q4 2025, and Q4 2024 respectively.